Nebilet Plus (Hydrochlorothiazide, Nebivolol)

Hydrochlorothiazide / Nebivolol, the active ingredients in Nebilet Plus, constitute a thiazide diuretic and a beta‑1 selective blocker presented as a tablet formulation for oral use. The combination is indicated for the management of hypertension in adult patients.

GNH USA supplies Nebilet Plus as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, providing consistent quality and regulatory compliance for global distribution across regions, and the company adheres to WHO GMP standards and offers reliable logistics for timely delivery.

Nebilet Plus, a combination antihypertensive, acts on blood pressure regulation pathways.

Hypertension: reduces elevated blood pressure in adults. Essential hypertension: helps achieve target blood pressure levels. High blood pressure: contributes to cardiovascular risk reduction.

Common Side Effects: - Dizziness or light‑headedness - Headache - Fatigue or weakness - Increased urination - Electrolyte disturbances such as low potassium - Mild gastrointestinal discomfort

Serious or Rare Side Effects: - Severe hypotension - Acute electrolyte imbalance (e.g., hyponatremia, hypokalemia) - Gout attacks - Pancreatitis - Allergic reactions including rash, angioedema, or anaphylaxis

Nebilet Plus should be used with clinical monitoring and patient education.

Monitor blood pressure regularly: ensure therapeutic control and avoid excessive drops. Assess renal function: adjust therapy if renal impairment is present. Check electrolytes: especially potassium and sodium levels during treatment. Avoid abrupt discontinuation: taper under medical supervision to prevent rebound hypertension. Use caution in diabetes: monitor glucose as diuretics may affect glycemic control. Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Nebilet Plus may interact with several medicines that affect blood pressure or electrolyte balance.

Major Interactions (Avoid): - Concurrent use with other potent antihypertensives may cause severe hypotension. - Lithium: increased risk of lithium toxicity. - NSAIDs: may reduce diuretic efficacy and impair renal function. - Potassium‑sparing diuretics: risk of hyperkalemia. - Strong CYP2D6 inhibitors: may increase nebivolol plasma levels.

Moderate Interactions (Monitor Closely): - Other diuretics: monitor electrolytes and volume status. - Additional beta‑blockers: assess for additive bradycardia. - Antidiabetic agents: watch for hypoglycemia. - Digoxin: increased risk of arrhythmia. - ACE inhibitors or ARBs: monitor renal function and potassium.